Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D....
Transcript of Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D....
![Page 1: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/1.jpg)
Carmen Raventos-Suarez [email protected]
(609-252-6492)
Bristol-Myers Squibb
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
![Page 2: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/2.jpg)
When We Study Cells
FACS Answers presented on this workshopProliferation: What When and HowArrest: Why “When” is a key featureApoptosis: Dealing with the kinetics of a
disappearing population
At the microscope we can visualize many structures inside the cells
Photographs from Molecular Probes web site
![Page 3: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/3.jpg)
ProliferationWhat?
A cycling phenomena regulated by check point controlsDNA duplication followed by segregation into two new entities
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
![Page 4: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/4.jpg)
Proliferation
• Basic science research– signal transduction evaluation
• Pharmaceutical industry– biochemical to cellular assays
• Clinical follow up– cancer therapeutic efficiencies– inflammatory cascades identification– immune activation responses
When do you measure it?
![Page 5: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/5.jpg)
Cell Cycle Profile Components
G0/G1
S G2/M
DNA (area)
Cell Questsoftware
Sub-G1 Tetraploid
A picture of DNA Synthesis
![Page 6: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/6.jpg)
Cell Cycle Profiles:A Personal Signature of Cells
DNA histograms gives a first hint about cells proliferation potential
DNA-PI
Slow growth Fast growth
![Page 7: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/7.jpg)
Proliferation Features
What does “Cell Cycle Profiles” really mean?
0
200
400
600
800
1000
FL2-A: PI Sparse
Logaritmic
Confluent
A2780WT
0
200
400
600
800
1000
FL2-A: PI
A2780DDP
Confluent
Logaritmic
Sparse
FlowJo Software
![Page 8: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/8.jpg)
• DNA content and population distributions
G150%
S30%
G2/M 20%
24h Cell cycle 12hrs 7.2hrs 4.8hrs
G140%
S38%
G2/M 22%
24h
24h
new cycle
18h Cell cycle 7.2 hrs 6.8 hrs 3.9hrs 6h additional hours of growth
Number of cells =100
Number of cells =125
Cell Cycle Times and Numbers
![Page 9: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/9.jpg)
When A Cell Divides
Modified from Cell Signaling Web site
G1
S
G2/M
Addressing cells one at a time
![Page 10: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/10.jpg)
Getting The Components Right
The Question of Doublet Discrimination
Alternatively Area vs. Height is also a way to discriminate doublets and higher clumps
FlowJo Software
![Page 11: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/11.jpg)
Cell Cycle Profile of Single Cells
Gated vs. non gated populations Previous plots
0 200 400 600 800 1000FL2-A: DNA-PI
0
200
400
600
# C
ells
single cells
%G1
%S
%G2
%<G1
%>G2
28.9
22.6
38.2
10.6
-0.47
0 200 400 600 800 1000FL2-A: DNA-PI
0
200
400
600
# C
ells
Ungated
%G1
%S
%G2
%<G1
%>G2
26.3
17.3
30.1
18
9.24
0 200 400 600 800 1000FL2-A: FL2-Area
0
500
1000
1500
# C
ells
Single cells
%G1
%S
%G2
%<G1
%>G2
75.5
14.9
3.84
4.05
0.82
0 200 400 600 800 1000FL2-A: FL2-Area
0
500
1000
1500
# C
ells
Ungated
%G1
%S
%G2
%<G1
%>G2
64.5
15.1
7.35
7.14
4.58
0 200 400 600 800 1000FL3-A: DNA-7AAD
0
100
200
300
400
# C
ells
single cells
%G1
%S
%G2
%<G1
%>G2
21.8
48.9
25.4
0.8
3.49
0 200 400 600 800 1000FL3-A: DNA-7AAD
0
100
200
300
400
# C
ells
Ungated
%G1
%S
%G2
%<G1
%>G2
12.4
26.5
23.8
2.05
35.9
FlowJo Software
![Page 12: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/12.jpg)
Nuclei vs. Whole Cells
Nuclei
•Ploidy paraffin blocks
•Apoptosis problems
•Nuclear localization
Whole cells
•Ploidy fresh samples
•Apoptosis efficiency
•Cytoplasmic markers.
What is better?
![Page 13: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/13.jpg)
Cell Cycle Software Packages
• Multicycle• Modfit• FlowJo All are packages that contain algorithms with
different restrictions bound to their calculations.Unfortunately, no algorithms are consistently reliable in fitting all thedistributions you may encounter. You may have to experiment with differentoptions and constraints in finding your best results. (copied FlowJo quote)
Getting Numbers to Fit Your Data
![Page 14: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/14.jpg)
Getting To See The NumbersWatson Pragmatic vs. Dean Jett Fox in FlowJo software
Alice Givan previously showed the Mod Fit variations on their selective options
0 200 400 600 800 1000FL2-A: DNA-PI
0
200
400
600
# C
ells
0 200 400 600 800 1000FL2-A: DNA-PI
0
100
200
300
400
# C
ells
0 200 400 600 800 1000FL2-A: DNA-PI
0
200
400
600
800
1000
# C
ells
single
%G1
%S
%G2
47.7
32.2
14.5
single
%G1
%S
%G2
18.4
35.1
36.8
single
%G1
%S
%G2
22.8
31.5
35.7
0 200 400 600 800 1000FL2-A: DNA-PI
0
200
400
600
# C
ells
0 200 400 600 800 1000FL2-A: DNA-PI
0
100
200
300
400
# C
ells
0 200 400 600 800 1000FL2-A: DNA-PI
0
200
400
600
800
1000
# C
ells
single
%G1
%S
%G2
48.8
26.2
20.6
single
%G1
%S
%G2
22.3
28.3
40.5
single
%G1
%S
%G2
25.1
29.8
37.5
![Page 15: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/15.jpg)
Precautions-Tissue Culture Monolayers
• Learn the metabonomics of your cells– Doubling times, density optimization
• Cell Culture Stocks Maintenance– Rigid protocol for split times/avoid overgrowth
• Protocol for Experimental Tests– Standardized number of cells & scheduling– Efficiently trypsinize to a unicellular suspension
![Page 16: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/16.jpg)
• Adding a second marker to your cells– Cell identification markers (CD’s or signal transduction probes)– DNA doubling features, BrdU incorporation
• Adding a third or more markers to your cells– When preset configuration is fixed in your instrument
Search for probes that allow to you the best combinations on added color– When you are able to set up your own configuration
First pick up different lasers then change your dichroics and band filters
Beyond DNA Quantitative Analysis
How to add more significance to your data?
![Page 17: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/17.jpg)
Proliferation and BrdU
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
0 200 400 600 800 1000FL2-A
1
10
100
1000
10000
FL1-H
K562
A2780S
30min pulse 5hrs release 8hrs release
FlowJosoftware
S phase and Doubling Times
![Page 18: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/18.jpg)
Calculating the Numbers
From: Cell Cycle Kinetics Estimated by Analysis of Bromodeoxyuridine Incorporation. Terry N.H.A., and White A. Methods in cell Biology 63:355-374 (1994)
Getting the mathematics to work for you
![Page 19: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/19.jpg)
Overall messages
• When to do DNA?– Maybe every time you address cells
• Watch out! Single cells exclusively– Cell preparation. Avoid clumping
• How to address specific questions?– Cell culture conditions. Use tight protocols– Most appropriate software. Up to you
![Page 20: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/20.jpg)
References• Solid Tumor dissociation and storage (nuclei)
– Cerra.R., Zarbo R.J., and Crissman. JD.,1990 Dissociation of cells from Solid Tumors. Methods inCell biology 33: 1-12
– Vindelov.L.L.,Cristensen.IJ. An integrated set of methods for routine flow cytometry DNAAnalysis. 1990. Methods in Cell biology 33: 127-137
• Cell Lines (whole cells)– Pozarowwski.P., Darzynkiewiwicz.Z. Analysis of Cell Cycle by Flow Cytometry. 2004. Methods
Mol Biol 281:301-311.– Traganos.F.,Juan.G.,Darzynkiewiwicz.Z. Cell Cycle Analysis of Drug treated Cells 2001. Methods
Mol Biol 95:229-240.
• Overall– Rabinovitch.P.S. Practical considerations for DNA Content and Cell Cycle Analysis in Clinical
Flow Cytometry. Principles and applications. Williams and Wilkins-1993– Pham.NA., Jaccobberger.JW.,Schimmer.A.D.,Cao.P.,Gronda.M.,Hedley.D.W. 2004. The dietary
isothiocyanate sulforaphane targets pathways of apoptosis,cell cycle arrest, and oxidative stress inhuman pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficientmice. Mol.Cancer.Ther.3:1239-1248
– Bagwell.B. et al. 2004. Optimizing Flow Cytometric DNA ploidy and S phase Fraction asnNegative prosnostic Markers for Node-Negative Breast Cancer Specimens Cytometry 46:121-135
![Page 21: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/21.jpg)
Proliferation Disturbances
Arrest
A Way to Cope with Stress
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
![Page 22: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/22.jpg)
• A slowdown in cell cycle progression?• A reversible or irreversible block in one phase of
the cycle?• An induced effect of stress or toxic insult?• A response of the cell genetic makeup?• All of the above?
ARRESTWhat is it?
![Page 23: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/23.jpg)
The Meaning of Cell Cycle Arrest
Control Campthothecin Cisplatin Paclitaxel
Cell growth arrest induced by stress or chemical compounds are efficiently identified when cells are growing at their optimal logarithmic rates and inducers are at an equilibrium concentration where cells are halted to activate repair mechanisms or apoptosis
Cell Questsoftware
How Do You Identify Specific Growth Arrest?
![Page 24: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/24.jpg)
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
CellQuest software
Identification of Arrest
Laidlaw, J., Raventos-Suarez,C., Fairchild, C.R., Peterson, R.W., and Menendez, A.T. Taxol and taxotere have similar potency in cytotoxicity assays, cell selectivity, bcl-2 phosphorylation, G2/M arrest and induction of apoptosis.91st Annual meeting of the AACR. San Francisco, April 1-5. 2000.
Titrations
Paclitaxel a model drug for G2/M arrest
![Page 25: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/25.jpg)
FlowJo Software
LnCaPCamptothecin
0200
400600
8001000FL2-A: DNA-PI
Control none
1nM
3nM
10nM
30nM
100nM
0200
400600
8001000FL2-A: DNA-PI
Control none
1nM
3nM
10nM
30nM
100nM
A2780Camptothecin
More titrations
Camptothecin a Model drug for S arrest?
Identification of Arrest
![Page 26: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/26.jpg)
• Preliminary Requirements– Cytotoxic tests provide the best tool to identify dosage
• Cell Cycle Titration Curves– Cell cycle profiles need to be address one cycle of
growth at a time– Preliminary titration curves done at a 24h time point
provide good hints of activity
How to Evaluate a Compound
![Page 27: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/27.jpg)
Arrest As An Assay
• The Story of BMS-250497– BMS-250497 is the first non camptothecin compound
described to be specific for Topoisomerase I inhibition.– Because of the side effects of camptothecin another
efficient compound with this kind of activity have beenactively pursued by the pharmaceutical industry
– Biochemical assays required confirmation at the cellularlevel to reinforce the value of this compound as a candidatefor the clinic
Mechanism of Action
![Page 28: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/28.jpg)
Results on BMS-250749
Control 0.1x 1x 5x 10x 20x IC50
• Flow cytometryanalysis of A2780cells with wt p53
• Effects ofBMS-250749 andcamptothecin
CamptothecinIC50 = 10 nM
BMS-250749IC50 = 3 nM
CellQuest software
-Raventos-Suarez,C., Class. K., Buczek,J,L.,Balasubramanian,N., Long, B., and Menendez, A,T. 2001 Topoisomerase I is the Target Responsible for Cytotoxicity of BMS-250749: Confirmation by Flow Cytometry 92th Annual Meeting, New Orleans March 24-28; Proc. AACR 2001 42:103 Abs 562-Raventos-Suarez,C., Class, K., Wild, R., Menendez, A., Long, B. 004 IN VITRO Specificity Profiling of Cellular Topoisomerase Activities Using FACS Analyses.2ISAC XXII International Congress on Analytical Cytology. May22-27 2004 Montpellier, France. Cytometry 58A: p115 Abst# 96207
![Page 29: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/29.jpg)
In Arrest Profiles
488nm laser 633nM laser 488nm laser 633nM laser
HCT116 HCT116 (VM46)
DNA Cell Cycle Profiles
HCT116 HCT116(VM46)
Cyclin B1 Profiles
Comparison between PI and ToPro3 Blue= 488nm Red=633nm
DNA Cyclin B1 Cyclin E Cyclin A
0 200 400 600 800 1000FL4-A: FL4 A
0
200
400
600
800
1000
FL
2-H
: F
L2
-He
igh
t
0 200 400 600 800 1000FL4-A: FL4 A
0
200
400
600
800
1000
FL2-
H:
FL2-
Hei
ght
0 200 400 600 800 1000FL4-A: FL4 A
0
200
400
600
800
1000
FL1
-H:
FL1
-Hei
ght
0 200 400 600 800 1000FL4-A: FL4 A
0
200
400
600
800
1000
FL1-
H: F
L1-H
eigh
t
Control cells
Camptothecin treated
A second parameter reinforced your observations
![Page 30: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/30.jpg)
FlowJo Allows Line Graphs Over DNA Profiles
Cyclin E
Cyclin A
A second parameter always reinforced your observations
![Page 31: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/31.jpg)
• We used a panel of 3 paired cell lines:sensitive and resistant to identify activity
• It takes several comparisons to efficientlyconfirm at the cellular level effects ofknown activities from a biochemical assay
Results on BMS-250749
![Page 32: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/32.jpg)
Arrest Leads into Apoptosis
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
![Page 33: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/33.jpg)
Apoptosis
An active metabolic processdevised to dismiss stressed cells
unable to cope with the insult
An active act of disappearance
![Page 34: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/34.jpg)
Morphology of Apoptosis
Control Apoptotic
![Page 35: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/35.jpg)
Apoptosis Pictures
Apoptosis a disappearing population
![Page 36: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/36.jpg)
Evaluation Methods
• Annexin V• TdT Tunel• p85PARP• Caspase 3• Many other caspases• Other approaches- The Sub G1 fraction
Best When Linked to DNA profiles
![Page 37: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/37.jpg)
Tunel Assay
Flow Josoftware
0 200 400 600 800 1000FL2-A: DNA-PI
100
101
102
103
104
FL1-H
: dU
TP
-F
ITC
single cells
apoptosis
0 200 400 600 800 1000FL2-A: DNA-PI
100
101
102
103
104
FL1-H
: dU
TP
-F
ITC
single cells
apoptosis
0 200 400 600 800 1000FL2-A: DNA-PI
100
101
102
103
104
FL1-H
: dU
TP
-F
ITC
single cells
apoptosis
0 200 400 600 800 1000FL2-A: DNA-PI
100
101
102
103
104F
L1-H
: dU
TP
-FIT
C
single cells
apoptosis
Dot Plot Overlays
Provides Specificity of Phase
![Page 38: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/38.jpg)
p85PARP on Drug Effects
0 200 400 600 800 1000FL2-A: PI-DNA
1
10
100
1000
10000
FL1-
H: P8
5-FIT
C
0 200 400 600 800 1000FL2-A: PI-DNA
1
10
100
1000
10000
FL1-
H: P8
5-FIT
C
Vinblastin 5nM Colchicine 10nM
Flow Josoftware
Localization of populations engaged in apoptosis
![Page 39: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/39.jpg)
Apoptosis by Sub-G1, an increasingly growing population
0
200
400
600
800
1000FL2-A: DNA-PI Control
Low dose
High dose
**
*
*
The Sub-G1 Fraction
![Page 40: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/40.jpg)
When Proliferation, Arrestand Apoptosis Meet
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
A2780/DDP-R
DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE
A2780/DDP-S
Taxol
Taxotere
Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM
![Page 41: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/41.jpg)
The Story of BMS-214662
– BMS-214662 is a farnesyl transferase inhibitor withhigh apoptosis induction capabilities.
– Targets on the farnesyl transferase cascade are notexpected to produce any apoptosis in short periods oftime but this compound did it
– An assay needed to be devised to stain forproliferation and apoptosis simultaneously to directlyanswer this question
-Raventos-Suarez,C., Class. K. and Lee F. 2002 The pro-apoptotic FT-inhibitor BMS-214662 selectively targets non-proliferating tumor cells. Demonstration by a new flow cytometric method. ISAC XXI International Congress on AnalyticalCytology .May 2002 San Diego, California. Cytometry supp11: p72
![Page 42: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/42.jpg)
Building An Assay
• Proliferation by BrdU Uptake andevaluation by Dnase treatment: modify theBrdU Flow Kit from BD cat#552598”
• Cell cycle profiles by DNA 7AAD stain• Apoptosis by p85 PARP “use the Anti-PARP p85 fragment Ab from
Promega” cat#G734A”
![Page 43: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/43.jpg)
Cisplatin 500nM BMS-214662 9uM
Proliferation and Apoptosis
P
A P+A A P+A
P
Red = non proliferatingBlue = proliferatingGreen = apoptotic non proliferatingP+A = proliferating cells engaged in apoptosis
Control
A P+A
P
Mechanism of Action of BMS-214662
![Page 44: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/44.jpg)
Take Home Messages
• Cell Cycle Profiles are the best handle inaddressing cell behavior, capacity to respond toan stimulus and possible engagement inapoptosis
• Careful preparation of cells is essential
• Multiparameter analysis linked to cell cycleprofiles provide a more complete picture ofcellular activities
![Page 45: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/45.jpg)
Back up data
![Page 46: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/46.jpg)
Cell Cycle Profile of CellsGetting to see the numbers
When algorithms don’t seem to fit you can force constrains
FlowJo Software
![Page 47: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/47.jpg)
Cell Cycle Profile of CellsA cell specific signature
Why are times at logarithmic rate of growth taken as optimal?
0200
400600
8001000FL2-A: PI
HCT116
HCT116(VP35)
HCT116(VM46)
A2780/DDP-R
A2780/Tax
A2780/DDP-S
Panel of cell lines growing at logarithmic growth ratesFlowJo Software
![Page 48: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/48.jpg)
Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50
P388 (24h) P388 (48h)
Camptothecin IC50= 10nM
BMS-250749 IC50=3nM
Etoposide IC50= 1.2uM
Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50
P388/Topo I (48h)P388/Topo I (24h)
Camptothecin IC50= 10nM
BMS-250749 IC50=3nM
Etoposide IC50= 1.2uM
Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50
HCT116/TopoII (24h) HCT116/TopoII (48h)
Camptothecin IC50= 10nM
BMS-250749 IC50=3nM
Etoposide IC50= 1.2uM
Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50
HCT116 (48h)
Camptothecin IC50= 10nM
BMS-250749 IC50=3nM
Etoposide IC50= 1.2uM
HCT116 (24h)
Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50
A2780mutp53 (24h) A2780mutp53 (48h)
Camptothecin IC50= 10nM
BMS-250749 IC50=3nM
Etoposide IC50= 1.2uM
Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50
A2780mutp53 (24h) A2780mutp53 (48h)
Camptothecin IC50= 10nM
BMS-250749 IC50=3nM
Etoposide IC50= 1.2uM
Results on BMS-250749 Six cell lines two time points plus two control drugs
It takes a panel of comparisons to address population distribution effectsShown are Cells in 3 pairs:sensitive/resistant (TopoII, TopoI and p53)
![Page 49: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/49.jpg)
• Proliferation activities require more than DNAmeasurements to account for disturbances– BrdU assay
• will identify the S phase and determine doubling times.– Mitotic markers:
• will allow discrimination of G2 and S phases– Cyclins:
• will determine how far into a cell cycle phase cells have beenable to go before stop growing
– Specific altered functions by induced by resistance ormutation mechanisms
Proliferation What and WhenBeyond DNA quantitative analysis
![Page 50: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES](https://reader033.fdocuments.net/reader033/viewer/2022042223/5ec9e6ae61cc052c001698e0/html5/thumbnails/50.jpg)
Control Camptothecin Etoposide TAS-103
Control Camptothecin Etoposide TAS-103
More on Mechanism of Action Specificity on Topo II
Long, B.H., Fairchild, C.R., Raventos-Suarez,C., Cornell, L., and Menendez, A.T. Cytotoxic mechanism of TAS-103 is related to topoisomerase II mediated DNA cleavage. 91st Annual meeting of the AACR. San Francisco, April 1-5, 2000.
A Camptothecin ResistantCell line
A Camptothecin SensitiveCell line
Cell Questsoftware